Q4 2024 Holdings
Filed 2025-02-14 | 171 holdings | $735.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $67.5M | 750,000 | 9.2% |
| Spdr SER TR(XBI)Call | S&P BIOTECH | 78464A870 | $63.0M | 700,000 | 8.6% |
| Tyson Foods Inc(TSN)Put | CL A | 902494103 | $36.2M | 630,000 | 4.9% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $33.6M | 607,689 | 4.6% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $26.4M | 516,431 | 3.6% |
| Amgen Inc(AMGN)Call | COM | 031162100 | $19.3M | 74,000 | 2.6% |
| Bridgebio Pharma Inc(BBIO)Call | COM | 10806X102 | $19.2M | 700,000 | 2.6% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $15.4M | 357,185 | 2.1% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $14.8M | 169,374 | 2.0% |
| Forte Biosciences Inc(FBRX) | COM NEW | 34962G208 | $13.8M | 609,225 | 1.9% |
| Pilgrims Pride Corp(PPC)Put | COM | 72147K108 | $13.6M | 300,000 | 1.9% |
| Avidity Biosciences Inc(RNA)Put | COM | 05370A108 | $11.6M | 400,000 | 1.6% |
| Insmed Inc(INSM)Call | COM PAR $.01 | 457669307 | $10.4M | 150,000 | 1.4% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $9.8M | 81,000 | 1.3% |
| Neumora Therapeutics Inc.(NMRA)Call | COM | 640979100 | $9.5M | 900,000 | 1.3% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $9.0M | 469,949 | 1.2% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $8.9M | 394,538 | 1.2% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $8.8M | 291,240 | 1.2% |
| Axsome Therapeutics Inc(AXSM)Call | COM | 05464T104 | $8.5M | 100,000 | 1.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $8.3M | 119,800 | 1.1% |
| CAL Maine Foods Inc(CALM)Put | COM NEW | 128030202 | $7.7M | 75,000 | 1.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $7.7M | 284,085 | 1.0% |
| Ginkgo Bioworks Holdings Inc(DNA)Call | CL A NEW | 37611X209 | $7.6M | 769,700 | 1.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $7.5M | 178,989 | 1.0% |
| Immunovant Inc(IMVT)Call | COM | 45258J102 | $7.4M | 300,000 | 1.0% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $7.3M | 349,649 | 1.0% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $7.2M | 970,259 | 1.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $7.1M | 149,982 | 1.0% |
| Dyne Therapeutics Inc(DYN)Put | COM | 26818M108 | $6.6M | 280,800 | 0.9% |
| VIR Biotechnology Inc(VIR) | COM | 92764N102 | $6.6M | 897,862 | 0.9% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $6.6M | 142,328 | 0.9% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $6.6M | 282,159 | 0.9% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $5.9M | 215,713 | 0.8% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $5.7M | 576,166 | 0.8% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $5.6M | 378,363 | 0.8% |
| Akero Therapeutics Inc(AKRO)Put | COM | 00973Y108 | $5.5M | 199,000 | 0.8% |
| Beigene LTD(ONC)Call | SPONSORED ADR | 07725L102 | $5.5M | 29,800 | 0.7% |
| Bright Minds Biosciences Inc(DRUG) | COM NEW | 10919W405 | $5.5M | 152,211 | 0.7% |
| VIR Biotechnology Inc(VIR)Call | COM | 92764N102 | $5.3M | 720,300 | 0.7% |
| Celldex Therapeutics Inc New(CLDX)Put | COM NEW | 15117B202 | $5.2M | 205,500 | 0.7% |
| Capricor Therapeutics Inc(CAPR)Call | COM NEW | 14070B309 | $5.0M | 361,100 | 0.7% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $4.6M | 1,126,637 | 0.6% |
| Alpha Cognition Inc(ACOG) | COM NEW | 02074J501 | $4.5M | 755,867 | 0.6% |
| Scholar Rock Hldg Corp(SRRK)Call | COM | 80706P103 | $4.4M | 102,100 | 0.6% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $4.3M | 149,502 | 0.6% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $4.2M | 857,230 | 0.6% |
| Moderna Inc(MRNA)Put | COM | 60770K107 | $4.2M | 100,000 | 0.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $4.1M | 34,087 | 0.6% |
| Capricor Therapeutics Inc(CAPR)Put | COM NEW | 14070B309 | $4.1M | 300,000 | 0.6% |
| Evolus Inc(EOLS) | COM | 30052C107 | $4.1M | 373,265 | 0.6% |